Physician profile
Dalya Yebra
NPI 1578034450
$8,002.42
in general payments reported to CMS, 2019-2025
17 companies · $351 in 2025
The $351 reported for 2025 was more than what 78% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $366 · 2022: $634 · 2023: $6,408 · 2024: $243 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $1,001.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $6,397.78 | 2022-2025 | Slynd, Nuvessa |
| Abbvie INC. | $749.84 | 2021-2025 | |
| Astellas Pharma US INC | $172.40 | 2022-2025 | Veozah |
| Hologic Sales and Service, LLC | $144.71 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $91.27 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $69.43 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $54.77 | 2022 | |
| Organon LLC | $53.05 | 2021-2023 | Nexplanon |
| Myovant Sciences INC. | $52.55 | 2022 | |
| Shield Therapeutics INC | $46.41 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.53 | 2022-2025 | |
| Coopersurgical, INC. | $34.13 | 2024-2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $24.24 | 2022 | |
| Therapeuticsmd, INC. | $23.08 | 2021 | |
| Millicent US INC | $16.69 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.51 | 2023 | Cologuard Collection Kit |
| Mission Pharmacal Company | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalya Yebra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.